Skip to content

LC LAB

Active
Private limited companyfounded 20188 yrs activeRue Liébin(H-A) 29, 7110 La Louvière, BelgiumKBO/BCE: BE 0698.703.470

LC LAB has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €145k and a net result of €7k. Equity is growing by ~20.1% per year across the filed fiscal years. Its solvency ranks better than 41% of 16206 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).

Checked score

Score 2025
89 / 100
Excellent▲ +35 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability26▲+20
Solvency77▲+8
Growth52=
Stability100
Bankruptcy probability, 12 months
0.4% Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €13k at 30 days acceptable
Liquidity tight (current ratio 1.16 against 0.87 in 2024), and 47.7% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 32
Relative position
BE, all sectors
reference
Sector 32
lower
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
52.3%
Return on assets
2.7%
Age of the figures
8 mo
raises risk · Higher-failure-rate region
In this region companies fail more often than in the rest of the country.
KBO · registered office
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 8 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-06-2026, 52 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
52 d early
2024
51 d early
2023
2 d late
2022
41 d early
2021
50 d late
2020
24 d late
2019
31 d early
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
08-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Turnover
€199k
EBIT margin
10.8%
Net result
€7k▲ 376%
2024 · €2k
2018: €12k 2019: €13k 2020: €35k 2021: €13k 2022: €40k 2023: €18k 2024: €2k
2018 → 2025
Working capital
€12k
2024 · €-11k
2018: €10k 2019: €21k 2020: €73k 2021: €57k 2022: €1k 2023: €17k 2024: €-11k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Turnover€199k-
Equity€78k-€118k▲ 50.4%€136k▲ 15.0%€137k▲ 1.2%€145k▲ 5.4%
Operating result€21k-€50k▲ 133%€28k▼ 44.9%€7k▼ 72.9%€19k▲ 150%
Net result€13k-€40k▲ 208%€18k▼ 55.4%€2k▼ 91.1%€7k▲ 376%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
€0€20k€40kOperating result 2021: €21k€21kNet result 2021: €13k€13kOperating result 2022: €50k€50kNet result 2022: €40k€40kOperating result 2023: €28k€28kNet result 2023: €18k€18kOperating result 2024: €7k€7kNet result 2024: €2k€2kOperating result 2025: €19k€19kNet result 2025: €7k€7k20212022202320242025
The operating result recovers in 2025; 2025 is 150% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €277k
Fixed assets €186k▼ 12.1%
Current assets €90k▲ 31.2%
Equity and liabilities €277k
Equity €145k▲ 5.4%
Debt €132k▼ 8.1%
The debt ratio falls from 51.1% to 47.7%: equity grows while debt is paid down.
Key figures and ratios
2025 value · change against 2024
EBITDA
€45k
2024 · €28k
Cash flow
€34k
2024 · €22k
Solvency
52.3%
2024 · 48.9%
Current ratio
1.16
2024 · 0.87
Quick ratio
1.16
2024 · 0.87
Debt / equity
0.91
2024 · 1.05
ROE
5.2%
2024 · 1.1%
ROA
2.7%
2024 · 0.6%
Interest coverage
22.55
2024 · 12.87
Debt
€132k
2024 · €144k
Debt ≤ 1 year
€78k
2024 · €80k
Debt > 1 year
€54k
2024 · €64k
Income taxes
€10k
2024 · €4k
Staff costs
€114k
2024 · €41k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€281k€277k
Fixed assets21/28€212k€186k
Tangible fixed assets22/27€212k€186k
Land and buildings22€109k€106k
Plant, machinery and equipment23€54k€47k
Furniture and vehicles24€47k€32k
Other tangible fixed assets26€2k€2k
Financial fixed assets28€30€30=
Current assets29/58€69k€90k
Amounts receivable within one year40/41€43k€53k
Trade receivables40€38k€53k
Other amounts receivable41€4k-
Cash at bank and in hand54/58€23k€32k
Deferred charges and accrued income490/1€3k€5k
Equity and liabilities
Total equity and liabilities10/49€281k€277k
Equity10/15€137k€145k
Contributions10/11€6k€6k=
Reserves13€2k€2k=
Distributable reserves133€2k€2k=
Profit (loss) carried forward14€129k€137k
Amounts payable17/49€144k€132k
Amounts payable after more than one year17€64k€54k
Financial debts170/4€64k€54k
Amounts payable within one year42/48€80k€78k
Current portion of amounts payable after more than one year42€20k€10k
Trade debts44€7k€13k
Suppliers440/4€7k€13k
Taxes, remuneration and social security45€17k€17k
Taxes450/3€10k€4k
Remuneration and social security454/9€6k€13k
Other amounts payable47/48€36k€38k
Income statement Code20242025
Remuneration, social security and pensions62€41k€114k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20k€26k
Other operating charges640/8€2k€5k
Non-recurring operating charges66A-€756
Gross operating margin9900€71k€165k
Operating profit (loss)9901€7k€19k
Financial income75/76B€47€598
Recurring financial income75€47€26
Non-recurring financial income76B-€572
Financial charges65/66B€2k€2k
Recurring financial charges65€2k€2k
Non-recurring financial charges66B€40-
Profit (loss) for the period before taxes9903€5k€17k
Income taxes67/77€4k€10k
Profit (loss) for the period9904€2k€7k
Profit (loss) for the period to be appropriated9905€2k€7k
Appropriation of the result
Profit (loss) to be appropriated9906€129k€137k
Profit (loss) brought forward from the previous period14P€128k€129k

The notes to these accounts (11 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
09-06
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
2025
10-06
NBB filing Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial Weakest financial yearnet €2k ▼91.1%
Net result drops to €2k, the lowest in the series; recovery starts the following year.
02-08
NBB filing Annual accounts filed
fiscal year 2023 · micro schema · 2 days late
2023
20-06
NBB filing Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial Highest result since 2018net €40k ▲208%
Operating result €50k, net result €40k, both a record.
31-12
Financial Equity above €100kEq €118k ▲50.4%
5 profitable years in a row build equity to €118k.
19-09
NBB filing Annual accounts filed
fiscal year 2021 · micro schema · 50 days late
2021
24-08
NBB filing Annual accounts filed
fiscal year 2020 · micro schema · 24 days late
2020
30-06
NBB filing Annual accounts filed
fiscal year 2019 · micro schema
2019
25-06
NBB filing Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, La Louvière · 1 establishment unit since 2018
exact location from the address register On OpenStreetMap
Ground area
175 m²
Building footprint
119 m²
Volume, LiDAR
1,001 m³
Parcel 55019B0826/00T002, Wallonia · tallest building 10.6 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
LC LAB
Rue Liébin(H-A) 29, 7110 La LouvièreManufacture of medical and dental instruments and supplies
since 20182.277.735.291
1 parcel
Wallonia 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
55019B0826/00T002 Wallonia 175 m² 1 · 119 m² 10.6 m · 3 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,246 companies in sector 32500 we hold annual accounts for 692. 548 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded21-06-2018
Fiscal year end31-12
Activities, NACEBEL
32500Manufacture of medical and dental instruments and supplies
86901Human health activities
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 8 filingsAddress and cadastre registers

Data from official sources, last processed on 07-09-2026. Scores and ratios are computed by Checked and are not a credit decision.